gabapentin has been researched along with Dysgeusia in 1 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
Dysgeusia: A condition characterized by alterations of the sense of taste which may range from mild to severe, including gross distortions of taste quality.
Excerpt | Relevance | Reference |
---|---|---|
" We report here the first use of gabapentin in two glioblastoma patients who developed dysgeusia following intra-arterial administration of carboplatin or oral administration of lomustine, respectively." | 7.96 | Successful Management of Glioblastoma Chemotherapy-Associated Dysgeusia with Gabapentin. ( Fortin, D; Iorio-Morin, C; Touchette, CJ; Turcotte, K, 2020) |
" We report here the first use of gabapentin in two glioblastoma patients who developed dysgeusia following intra-arterial administration of carboplatin or oral administration of lomustine, respectively." | 3.96 | Successful Management of Glioblastoma Chemotherapy-Associated Dysgeusia with Gabapentin. ( Fortin, D; Iorio-Morin, C; Touchette, CJ; Turcotte, K, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Turcotte, K | 1 |
Touchette, CJ | 1 |
Iorio-Morin, C | 1 |
Fortin, D | 1 |
1 other study available for gabapentin and Dysgeusia
Article | Year |
---|---|
Successful Management of Glioblastoma Chemotherapy-Associated Dysgeusia with Gabapentin.
Topics: Administration, Oral; Dysgeusia; Gabapentin; Glioblastoma; Humans; Quality of Life | 2020 |